Canet G, Zussy C, Vitalis M, Morin F, Chevallier N, Hunt H, Claeysen S, Blaquière M, Marchi N, Planel E, Meijer OC, Desrumaux C, Givalois L. Advancing Alzheimer's disease pharmacotherapy: efficacy of glucocorticoid modulation with dazucorilant (CORT113176) in preclinical mouse models. Br J Pharmacol. 2025. doi: 10.1111/bph.17457.

Carles A, Freyssin A, Guehairia S, Reguero T, Vignes M, Hirbec H, Rubinstenn G, Maurice T. Neuroprotection by chronic administration of Fluoroethylnormemantine (FENM) in mouse models of Alzheimer's disease. Alzheimers Res Ther. 2025. 17(1):7.

Ferrero E, Vaz FM, Cheillan D, Brusco A, Marelli C. The ELOVL proteins: Very and ultra long-chain fatty acids at the crossroads between metabolic and neurodegenerative disorders. Mol Genet Metab. 2025 144(3):109050.

Micheau J, Catheline G, Barse E, Hiba B, Marcilhac A, Allard M, Platt B, Riedel G. PLB2_Tau mice are impaired in novel and temporal object recognition and show corresponding traits in brain MRI. Brain Res Bull. 2025. 220:111161.

Otaegui L, Urgin T, Zaiter T, Zussy C, Vitalis M, Pellequer Y, Acar N, Vigor C, Galano JM, Durand T, Givalois L, Béduneau A, Desrumaux C. Nose-to-brain delivery of DHA-loaded nanoemulsions: A promising approach against Alzheimer's disease. Int J Pharm. 2025.  7;670:125125.

Pradeau-Phélut L, Alvès S, Le Tareau L, Larralde C, Bernard E, Schirmer C, Lai-Kee-Him J, Lepvrier E, Bron P, Delamarche C, Garnier C. Efficient Biochemical Method for Characterizing and Classifying Related Amyloidogenic Peptides. Anal Chem. 2025. 97(2):1078-1086.

Tchan M, Lehman A, van Dussen L, Langendonk JG, Janssen MCH, Langeveld M, Murphy E, Ryder B, Glamuzina E, Merkel M, Sechi A, Arnoux JB, Mochel F, Alkemade G, Maillot F, Kaphan E, Mazodier K, Thomas Q, Leguy-Seguin V, Marelli C. The Frequencies of Different Inborn Errors of Metabolism in Adult Metabolic Centres: 10 Years Later, Another Report From the SSIEM Adult Metabolic Physicians Group. J Inherit Metab Dis. 2025, 48(2):e70005.